Innovating Works

LIFEGLIMMER GMBH

Desconocido
BIOINDUSTRY 4.0: RI services to promote deep digitalization of Industrial Biotechnology towards smart biomanufactur... Industrial Biotechnology (IB) is a Key Enabling Technology for the circular bio-economy, industrial renewal and European manufacturing auton...
2022-12-15 - 2026-12-31 | Financiado
EPHOR: Exposome project for health and occupational research LIFEGLIMMER GMBH participó en un H2020 H2020-SC1-BHC-2018-2020 Exposures at the workplace contribute to many non-communicable diseases (NCDs) with a similar magnitude as urban air pollution or obesity. G...
2019-12-06 - 2025-06-30 | Financiado
TranSYS: Translational SYStemics Personalised Medicine at the Interface of Translational Research and System... LIFEGLIMMER GMBH participó en un H2020 H2020-MSCA-ITN-2019 TranSYS will recruit 15 ESRs to highly skilled jobs in the new area of Systems Health developing tools and approaches to exploit large and c...
2019-08-19 - 2024-06-30 | Financiado
PERICO: Peroxisome Interactions and Communication LIFEGLIMMER GMBH participó en un H2020 H2020-MSCA-ITN-2018 PERICO fosters education of ESRs in a project to uncover how a central metabolic organelle, the peroxisome, participates in controlling cell...
2018-08-30 - 2023-03-31 | Financiado
IBISBA 1.0: Industrial Biotechnology Innovation and Synthetic Biology Accelerator LIFEGLIMMER GMBH participó en un H2020 H2020-INFRAIA-2016-2017 The overarching aim of IBISBA 1.0 is to support and accelerate the uptake of industrial biotechnology as a key enabling technology for advan...
2017-11-24 - 2022-05-31 | Financiado
HaemMetabolome: Deciphering the Metabolism of Haematological Cancers LIFEGLIMMER GMBH participó en un H2020 H2020-MSCA-ITN-2015 It has long been realised that metabolism is central to cellular development, proliferation and homeostasis. Collectively, aberrations in me...
2015-08-07 - 2019-09-30 | Financiado
EmPowerPutida: Exploiting native endowments by re factoring re programming and implementing novel control loops in... LIFEGLIMMER GMBH participó en un H2020 H2020-BIOTEC-2014-2015 We aim to engineer the lifestyle of Pseudomonas putida to generate a tailored, re-factored chassis with highly attractive new-to-nature prop...
2015-03-13 - 2019-04-30 | Financiado
Chromatin3D: Chromatin Dynamics in Development and Disease LIFEGLIMMER GMBH participó en un H2020 H2020-MSCA-ITN-2014 The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | Financiado
INFECT: Improving Outcome of Necrotizing Fasciitis Elucidation of Complex Host and Pathogen Signatures that... LIFEGLIMMER GMBH participó en un FP7 The overall goal with INFECT is to advance our understanding of the pathophysiological mechanisms, prognosis, and diagnosis of the multifact...
Financiado
SPLASH: Sustainable PoLymers from Algae Sugars and Hydrocarbons LIFEGLIMMER GMBH participó en un FP7 The 4-year SPLASH project will develop a new biobased industrial platform using microalgae as a renewable raw material for the sustainable p...
Financiado
SYSMEDIBD: Systems medicine of chronic inflammatory bowel disease LIFEGLIMMER GMBH participó en un FP7 Inflammatory bowel disease (IBD) is a major health problem with severe co-morbidities, requiring life-long treatment. Oscillating processes,...
Financiado
PERFUME: Peroxisomes key to cell performance and health LIFEGLIMMER GMBH participó en un FP7 The PERFUME (PERoxisome Formation, Function, MEtabolism) program is an interdisciplinary and intersectoral ITN providing state-of-the-art re...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.